A dark money anti-pharma bus —A rare disease treatment approval for Zevra —An FTC lawsuit against pharmacy benefit managers ...
Reuters reported that the court did not address the merits of the case, only that a Texas judge was wrong to dismiss it in February. Meanwhile, the Federal Trade Commission has accused the three ...
"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
The FTC’s complaint accuses Optum Rx and other pharmacy benefit managers of “abusing their economic power." Optum called the ...
The US Federal Trade Commission said that CVS Health's Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum ...
Meanwhile, at the end of last week the FTC announced it is taking legal action against the three pharmacy benefit managers ...
On Friday, the USA’s Federal Trade Commission (FTC) brought action against the three largest prescription drug benefit ...
The FTC is suing three pharmacy benefit managers for allegedly driving up the cost of insulin, but there is very little other ...
The Federal Trade Commission (FTC) has sued the top three pharmacy benefit managers (PBMs) in the US for operating a ...
At the Federal Trade Commission, Chair Lina Khan's mission is breaking illegal monopolies, blocking mergers that stifle ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback